Skip to main content
. 2008 Mar 10;336(7647):761–764. doi: 10.1136/bmj.39500.885752.BE

Table 1.

 Characteristics of contacts of patients with newly diagnosed leprosy (n=18 869, 87% of those included) after four years’ follow-up, by treatment allocation. Values are numbers (percentages of total numbers) of contacts

Variable Placebo group (n=9452) Rifampicin group (n=9417)
Age at intake (years):
 5-9 1497 (7.9) 1555 (8.2)
 10-14 1500 (7.9) 1488 (7.9)
 15-19 992 (5.3) 935 (5.0)
 20-29 1667 (8.8) 1587 (8.4)
 ≥30 3795 (20.2) 3852 (20.5)
Genetic distance to index patient:
 Closely related* 1475 (7.8) 1423 (7.5)
 Not closely related† 7977 (42.3) 7994 (42.4)
Male 4343 (23.0) 4354 (23.1)
Female 5109 (27.1) 5063 (26.8)
Type of disease in index patient:
 Multibacillary 2758 (14.6) 2486 (13.2)
 Paucibacillary with 2-5 lesions 2954 (15.7) 3254 (17.2)
 Single lesion paucibacillary 3740 (19.8) 3677 (19.5)
BCG scar absent 5552 (29.7) 5576 (29.8)
BCG scar present 3831 (20.5) 3760 (20.1)
Physical distance:
 Shares kitchen and house 863 (4.6) 880 (4.7)
 Shares kitchen only 687 (3.6) 684 (3.6)
 Shares house only plus is next door neighbour 2645 (14.0) 2425 (12.9)
 Neighbour of neighbour plus social contact‡ 5257 (27.9) 5428 (28.8)
ELISA result§:
 Negative¶ 8106 (47.0) 8137 (47.2)
 Positive** 515 (3.0) 494 (2.8)

ELISA=enzyme linked immunosorbent assay.

*Parent, child, or sibling.

†Other than parent, child, or sibling.

‡Business contacts and colleagues staying in same room at least four hours a day, five days a week.

§Contact population after two years’ follow-up.

¶Optical density <0.2.

**Optical density ≥0.2.